Prosecution Insights
Last updated: April 19, 2026
Application No. 17/864,465

HEAT RESISTANT CONFECTIONS

Final Rejection §103§112
Filed
Jul 14, 2022
Examiner
ZILBERING, ASSAF
Art Unit
1792
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Mars Incorporated
OA Round
6 (Final)
33%
Grant Probability
At Risk
7-8
OA Rounds
4y 9m
To Grant
60%
With Interview

Examiner Intelligence

Grants only 33% of cases
33%
Career Allow Rate
206 granted / 619 resolved
-31.7% vs TC avg
Strong +27% interview lift
Without
With
+27.2%
Interview Lift
resolved cases with interview
Typical timeline
4y 9m
Avg Prosecution
81 currently pending
Career history
700
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
57.9%
+17.9% vs TC avg
§102
10.2%
-29.8% vs TC avg
§112
26.0%
-14.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 619 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Status of Claims Note: The amendment of September 29th 2025 has been considered. Claims 1 and 11 have been amended. Claims 2-4 are cancelled. Claims 1 and 5-27 are pending in the current application. Claims 11-20 are withdrawn from consideration. Claims 1, 5-10 and 21-27 are examined in the current application. Any rejections not recited below have been withdrawn. Claim Rejections - 35 USC § 112 The text of those sections of Title 35 of the U.S. Code not included in this action can be found in a prior Office action. Claims 1, 5-10 and 21-27 are rejected under 35 U.S.C. 112(a), as failing to comply with the written description requirement. The claims contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventors, at the time the application was filed, had possession of the claimed invention. Regarding claim 1: The phrase “the ratio…is between 1:05 and 1:1.4” in line 5 of claim 1, is not disclosed in the original specification as argued by Applicant (see 3rd paragraph on page 6 of the 9/29/2025 “Remarks”). Accordingly, the claim is rejected under 35 USC 112(a) for failing to comply with the written description as it contains new matter. Clarification and/or correction is/are required. Regarding claims 5-10 and 21-27: In view of the fact that dependent claims 5-10 and 21-27 depend on independent claim 1, and since independent claim 1 is rejected under 35 U.S.C. 112(a) for failing to comply with the written description requirement, claims 5-10 and 21-27 are rejected for failing to comply with the written description requirement for depending on a claim that is failing to comply with the written description requirement of 35 U.S.C. §112(a). Claim Rejections - 35 USC § 103 In view the amendment and argument filed on September 29th 2025 the rejection of claims 1, 5-10 and 21-27 under 35 U.S.C. 103 over NPL Segur et al., “Sugar solubility sucrose and dextrose in aqueous Glycerol” in view of Moraly et al (US 6,451,122 B1), has been withdrawn. The closest prior art, Segur, discloses a sweetening mixture to be used in food, such as confections, comprising anhydrous dextrose and glycerol (i.e., a polyol) at ratios between 3:1 to 1:3, in order to avoid increasing the water content when dextrose monohydrate (i.e., glucose monohydrate) is used (see Segur abstract; page 567, left column; page 568, left column and tables 3-4). While Moraly discloses particle size plays a significant role in the flowability of dextrose monohydrate, with larger particles generally exhibiting better flow characteristics, while smaller particle sizes tend to lead to poorer flowability due to increased cohesion. Understanding and controlling particle size is important for optimizing processing and product performance, as dextrose monohydrate with particle size of at least 80µm provides improved flowability and functionality when used in fat based confectionaries (e.g, chocolate) (see Moraly abstract; column 1, lines 5-18, 30-33; column 4, lines 35-57; column 6, lines 52-60; Examples), neither Segur, Moraly, nor any other prior art reference disclose using the claimed dextrose monohydrate and polyol at the recited ratios. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ASSAF ZILBERING whose telephone number is (571)270-3029. The examiner can normally be reached M-F 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Erik Kashnikow can be reached at (571) 270-3475. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ASSAF ZILBERING/Examiner, Art Unit 1792 /ERIK KASHNIKOW/Supervisory Patent Examiner, Art Unit 1792
Read full office action

Prosecution Timeline

Jul 14, 2022
Application Filed
Apr 08, 2023
Non-Final Rejection — §103, §112
Jul 10, 2023
Response Filed
Oct 21, 2023
Non-Final Rejection — §103, §112
Feb 05, 2024
Applicant Interview (Telephonic)
Feb 05, 2024
Examiner Interview Summary
May 13, 2024
Non-Final Rejection — §103, §112
Aug 05, 2024
Response Filed
Nov 03, 2024
Non-Final Rejection — §103, §112
Mar 21, 2025
Response Filed
Jun 28, 2025
Non-Final Rejection — §103, §112
Sep 29, 2025
Response Filed
Feb 09, 2026
Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599143
EMULSIFIED OIL AND FAT COMPOSITION
2y 5m to grant Granted Apr 14, 2026
Patent 12588688
METHOD FOR PRODUCING AN INGREDIENT COMPRISING A COMBINATION OF AT LEAST THREE MILK PROTEINS AND USE OF THE INGREDIENT OBTAINED
2y 5m to grant Granted Mar 31, 2026
Patent 12582135
DHA Enriched Polyunsaturated Fatty Acid Compositions
2y 5m to grant Granted Mar 24, 2026
Patent 12577593
DHA ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS
2y 5m to grant Granted Mar 17, 2026
Patent 12564198
METHOD FOR MANUFACTURING SN-2 PALMITIC TRIACYLGLYCEROLS
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
33%
Grant Probability
60%
With Interview (+27.2%)
4y 9m
Median Time to Grant
High
PTA Risk
Based on 619 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month